Home › Employers › WuXi Biologics USA, LLC › Associate Scientist
Associate Scientist at WuXi Biologics USA, LLC: H-1B salaries
10 labor condition applications for the job title Associate Scientist at WuXi Biologics USA, LLC. Median offered base salary $70,000; middle half $64,814–$73,652.
Applications (LCAs)10
Median offered salary$70,000
Middle half of salaries$64,814–$73,652
10th–90th percentile$63,086–$76,263
By fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 5 | $70,000 |
| FY2024 | 1 | $74,870 |
| FY2025 | 4 | $63,086 |
Applications
| Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|
| $87,630 Level I | Cranbury, NJ | Jul 3, 2025 | Jul 7, 2025 | Certified |
| $63,086 Level I | Cranbury, NJ | May 15, 2025 | Oct 1, 2025 | Certified |
| $63,086 Level I | Cranbury, NJ | May 15, 2025 | Oct 1, 2025 | Certified |
| $63,086 Level I | Cranbury, NJ | May 15, 2025 | Oct 1, 2025 | Certified |
| $74,870 Level I | Cranbury, NJ | Jun 6, 2024 | Jun 6, 2024 | Certified |
| $70,000–$80,000 Level IV | Cranbury, NJ | May 4, 2023 | Oct 1, 2023 | Certified |
| $70,000–$80,000 Level I | Cranbury, NJ | Apr 18, 2023 | Oct 1, 2023 | Certified |
| $70,000–$80,000 Level I | Cranbury, NJ | Apr 18, 2023 | Oct 1, 2023 | Certified |
| $70,000–$80,000 Level I | Cranbury, NJ | Oct 25, 2022 | Nov 7, 2022 | Certified |
| $75,000–$85,000 Level I | Cranbury, NJ | Oct 4, 2022 | Oct 17, 2022 | Certified |
Associate Scientist at all employers →
Other jobs at WuXi Biologics USA, LLC
- Bioprocessing Associate II, MFG DSP$68,640
- Manager, Business Development, Research Services, East Coast$130,000
- Scientist II$85,000
- Marketing Manager$117,541
- Business Development Manager$120,000
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).